lundi 16 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· March 26, 2026

Resolutions from the Annual General Meeting of Novo Nordisk A/S

View original at finance.yahoo.com
Resolutions from the Annual General Meeting of Novo Nordisk A/S Novo Nordisk A/S Bagsværd, Denmark, 26 March 2026 – Today, Novo Nordisk A/S held its Annual General Meeting…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Novo Nordisk is reshaping its traditional approach to patient care and market access, needing to meet patients where they are

    60% confidence
  • The year ahead will test Novo Nordisk's determination and capabilities, but the company faces it with confidence

    60% confidence
  • Novo Nordisk's renewed focus, strengthened competencies and commitment to people with serious chronic diseases position them well for challenges and opportunities ahead

    60% confidence
  • 2025 was a year of profound transformation for Novo Nordisk

    60% confidence

Data points we hold from this source

Novo Nordisk A/S · final dividend per share7.95 DKK
Novo Nordisk A/S · dividend per share11.70 DKK
Novo Nordisk A/S · share par value0.10 DKK
Novo Nordisk A/S · authorized share repurchase limit10 percent
Novo Nordisk A/S · authorized share capital increase44650000 DKK
Novo Nordisk A/S · interim dividend per share3.75 DKK
Resolutions from the Annual General Meeting of Novo Nordisk A/S: Source | Via News | fr.via.news